This differential expression underscores the importance of Kv1.3 in the activation and growth of leukemia cells, highlighting its potential as a therapeutic target for controlling CLL cell proliferation [38,39]. The gene discussed is KCNA3; the disease is B-cell chronic lymphocytic leukemia.